Provider Comparison Matrix

Why the dose selector changes the order

Dose-scaled programmes rise as you climb while flat programmes do not, so the ranking at 0.25 mg is frequently not the ranking at 2.4 mg. Set the dose you expect to maintain on and the order rearranges itself.

Why you can filter to verified prices only

Because a comparison that silently mixes prices we read at the provider with figures copied from third-party round-ups is not a comparison. The filter lets you see only what we have confirmed, which is a shorter and more honest table.

What is not in the matrix

Shipping surcharges, one-off laboratory costs and anything billed irregularly. Those are on their own pricing pages, because folding occasional charges into a monthly figure would be its own distortion.

What the calculation assumes

The standard escalation: four weeks at 0.20.5 mg, four at 0.5 mg, then your chosen maintenance dose for the remainder. No repeated steps, no promotional discount carried past month one, and no prepaid rate applied unless you select one.

Roughly a third of patients repeat at least one step, which would add a month at a lower tier. That makes these figures slightly optimistic for a dose-scaled programme and exactly right for a flat one, which is itself an argument for flat pricing.

Why the answer changes when you change the dose

Dose-scaled programmes reprice as you climb; flat programmes do not. The cheapest programme at the 0.20.5 mg starter dose is frequently not the cheapest at 2.4 mg, and almost never the cheapest at 2.4 mg.

Because nobody knows their maintenance dose at intake, the defensible way to use this is to run it twice: once at the dose you expect and once at 2.4 mg. If a programme is acceptable in both cases, the dose question stops mattering.

What it cannot price

Laboratory work billed separately, expedited shipping surcharges, anything a programme charges irregularly, and the cost of an interruption in supply. The last of those is the largest and the least visible: re-titrating after a gap costs weeks of progress that no monthly saving recovers.

It also cannot price service quality. The cheapest tracked first year is about $1,740 through NexLife, and whether that is the right choice depends on things this tool does not measure.

Nothing here is transmitted

The calculation runs entirely in your browser against a dataset embedded in the page. There is no account, no email gate and no submission. Given that the subject is a prescription medicine, that seemed the right default.

What this calculator assumes

Four weeks at 0.20.5 mg, four at 0.5 mg, then your chosen maintenance dose. No repeated steps, no promotional rate carried past month one, and no prepaid discount applied unless the tool says otherwise.

Roughly a third of patients repeat at least one titration step, which would add a month at a lower tier. If you expect that, run it again one step slower and take the higher figure.

Where the numbers come from

The same file behind every table on this site: 32 programmes with all-in cost at five dose tiers, captured 2026-08-05, each carrying an evidence status. Prices marked verified were read on the provider's own page.

Nothing you enter is transmitted anywhere. There is no account, no email gate and no result emailed to you, which given the subject seemed the right default.

What it cannot tell you

Whether a programme ships on time, answers messages, or is clinically appropriate for you. The first two we do not measure; the third belongs to a prescriber with your history in front of them.

Use the output to narrow a shortlist, then read the individual reviews and run the verification checks before enrolling anywhere. The cheapest verified route currently sits at $145 a month all-in at a 2.4 mg maintenance dose.

Why this runs in your browser

No account, no email gate, nothing transmitted. Given that the subject is a prescription medicine and the inputs describe your dose and budget, that seemed the only defensible default.

It also means the result is not stored, so bookmark or screenshot anything you want to keep. The underlying dataset is downloadable if you would rather work in a spreadsheet.

What this calculator assumes

Four weeks at each step from 0.25 mg through 1.7 mg, then your chosen maintenance dose for the remainder. No repeated steps, no promotional rate carried past month one, and no prepaid discount unless the tool says otherwise.

A large share of patients hold at a step longer than four weeks. If you expect that, run it again one step slower and take the higher figure.

What it cannot tell you

Whether a programme ships on time, answers messages, or is clinically appropriate for you. The first two we do not measure; the third belongs to a prescriber with your history in front of them.

Use the output to narrow a shortlist, then read the individual reviews and run the verification checks before enrolling. The cheapest verified route currently sits at $145 a month all-in at a 2.4 mg maintenance dose.

The short version of provider comparison matrix

Price the dose you expect to hold, not the one in the advertisement. Add every recurring fee. Verify the pharmacy. Everything else on this page is detail underneath those three.

Done properly the answer is usually one of a handful of programmes: the cheapest verified route runs $145 a month all-in, about $1,740 across a first year including titration.

The next step that actually moves things

Send two or three programmes the same five questions: total at 2.4 mg including every fee, which pharmacy, is the prescriber licensed in my state, what notice to cancel and what is refundable, and which form of the active ingredient is used.

Whoever answers all five in writing has told you more than any comparison table can, this one included. Whoever does not has also told you something.

One thing worth doing annually

Re-price the market at your actual maintenance dose. No programme notifies existing patients when a competitor drops below it, and semaglutide pricing moved repeatedly through 2025 and 2026 — manufacturer cuts, an oral option, a higher-dose product, and several platforms leaving compounded entirely.

An hour once a year is a poor use of time for most purchases and an excellent one for a medication you may take for years.

Reading this alongside the rest of the site

Pricing pages isolate one component. Provider reviews carry the whole record for one programme. Comparisons run two side by side at every dose. The rankings sort the same dataset on different questions. None is the whole picture and none is meant to be.

If you read one other page, make it how to verify a pharmacy. Price is the easiest thing to compare and rarely the thing that goes wrong.

What we would need to change our mind

A programme publishing a figure at a dose tier currently blank. A named dispensing pharmacy with a checkable licence. A pricing model changing in either direction. A regulatory action. Or a correction from a reader with a source we can open.

All five are logged with the date they landed, on the change log and in the dataset. Prices here were captured 2026-08-05.

What this site will not do

Publish an estimated price for a programme that does not publish one. Rank a programme higher because it pays. Present a compounded preparation as equivalent to an approved product. Or carry a figure without the date it was captured.

Those four rules cost us pages, rankings and revenue, and they are the only reason a reader has to prefer this to a round-up assembled in an afternoon. A price without its date is not a fact, and a comparison built from undated prices is not a comparison.

Who this site is not for

Anyone with coverage under a documented indication, who should use it rather than read a cash comparison. Anyone looking for a source without a prescription, which this site will not help with. And anyone wanting a single confident recommendation, because the honest answer depends on your dose, your coverage and your tolerance for commitment.

If you want the short version anyway: price the dose you will hold, add every fee, verify the pharmacy, and avoid long prepaid terms until you have tolerated a maintenance dose for a cycle.